Post Transplant lymphoproliferative disorders (PTLD), the most common neoplasms in transplanted children are mostly associated with Epstein-Barr virus (EBV). The aims of our study were: 1. To describe, in a cohort of kidney transplant patients (KTx), cumulative incidence, incidence rate, time of onset (early <1 yr vs. late >1 yr), and clinical and histopathological characteristics of PTLD; 2. To compare patient and graft survival between those with and without PTLD and, in those EBV negative, association between peri-transplant administration of rituximab and primary EBV infection, EBV loads, and development of PTLD.
No takes yet. Share an insight, caveat, or question.
Gutiérrez et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: